Alexandria
Al Ahly complete historical treble, win Egypt Cup via penalties
Egyptian football giants, Al Ahly, crowned an extraordinary season by winning the 2019-20 Egypt Cup title on Saturday. By so doing, they completed a historical treble, having previously taken the 2019/2020 Egyptian Premier League trophy and the 2019/2020 Total CAF Champions League titles. On Saturday, after the tie against Talaea El Geish ended in a 1-1 draw, Al Ahly needed penalty shootouts which they won 3-2 at the Alexandria based Borg El Arab Stadium to extend their record by winning their 37th Egypt Cup title, ten more than arch-rivals Zamalek. Substitute Mahmoud Abdel Moneam “Kahraba” came from the bench to give Al Ahly the lead after 65 minutes. Only for Nasser Mansy to equalize for El Geish two minutes into injury time. As no more goals cake in the extra time, the game headed to pe...
US election: Republicans hold back Democrats, narrowing path to Senate control
The battle for power in the Senate tightened into Wednesday as Democrats picked up a seat in Colorado, but suffered a setback in Alabama, and Republicans held their own in high-profile races in South Carolina, Iowa, Texas and Kansas, dramatically narrowing the political map. Republicans fought to retain their Senate majority by turning back a surge of Democrats challenging allies of President Donald Trump, and the Democrats’ various paths to seizing control were growing more limited. With several contests still too early to call, and one Georgia race heading to a January runoff, the final verdict is expected to drag on. Democrats gained a seat when ex-Gov. John Hickenlooper ousted GOP Sen. Cory Gardner in Colorado, a must-win to flip the Senate, but couldn’t hold on in Alabama, where forme...
Gold rises on renewed US stimulus hope, dollar falls
Spot gold rose 0.3 percent to $1,910.56 an ounce at 3:37pm, New York time, after falling as much as 0.5 percent. Gold rose on renewed optimism for a preelection aid package in the U.S., while the dollar fell to a one-week low. House Speaker Nancy Pelosi said a bill for a compromise stimulus package is being written as she awaits a key phone call with Treasury Secretary Steven Mnuchin. Senate Majority Leader Mitch McConnell said his chamber would take up a comprehensive coronavirus package if an accord is struck. The Bloomberg Dollar Spot Index headed for the third straight decline. Pelosi said in a Bloomberg Television interview that while there are areas where more work is required to get a compromise, she was pleased with the Trump administration’s latest position on coronavirus testing ...
Plateau United coach seeks financial support to achieve Champions League Semi final target
Plateau United coach Abdu Maikaba has stated that they need the required support to meet the target of semi-finals of the 2020/2021 CAF Champions League. The former Akwa United coach admitted the 2017 NPFL champions will require even more backing and hard work to realize their last-four ambition in the competition – a feat which was last achieved by a Nigerian club – Sunshine Stars in 2012. “They (Plateau State Government) gave us enough support, but actually, we have to work very hard to achieve that target,” he said. “Getting to the semi-finals (of the CAF Champions League) is not an easy task, and we have to work very, very hard. We have to be given all the necessary support to get there. “In terms of personnel, like the replacement of players, I have to get the support to make the repl...
Pfizer, BioNTech dose U.S first participants of trial coronavirus vaccine
Pfizer Inc. and BioNTech SE announced on Wednesday, May 6, 2020, that the first participants have been dosed in the U.S in the Phase 1/2 clinical trial for the BNT162 vaccine program to prevent COVID-19. The trial is part of a global development program, and the dosing of the first cohort in Germany was completed last week. The Phase 1/2 study is designed to determine the safety, immunogenicity and optimal dose level of four mRNA vaccine candidates evaluated in a single, continuous study. The dose level escalation portion (Stage 1) of the Phase 1/2 trial in the U.S will enrol up to 360 healthy subjects into two age cohorts (18-55 and 65-85 years of age). The first subjects immunized in Stage 1 of the study will be healthy adults 18-55 years of age. Older adults will only be immunized with ...
